Laurus Labs Limited (LAURUSLABS.NS) - Stock Prices, Stock Peers & Analysis

Home
LAURUSLABS.NS

Company Name	Laurus Labs Limited
Symbol	LAURUSLABS.NS
Currency	INR
Price	470.4
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	253,620,393,600
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0.27%
52-week-range	349.4 - 518
Industry	Drug Manufacturers—Specialty & Generic
Sector	Healthcare
CEO	Dr. Satyanarayana Chava M.Sc., Ph.D.
Website	https://www.lauruslabs.com

An error occurred while fetching data.

About Laurus Labs Limited

Laurus Labs Limited, together with its subsidiaries, engages in the development, manufacture, and sale of medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company develops, manufactures, and sells APIs and advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C therapeutic